Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?

Trends in Neurosciences

Volumn 39, Issue 8, 2016, Pages 552-566

  Mander, Bryce A ^a   Winer, Joseph R ^a   Jagust, William J ^a,b   Walker, Matthew P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

aging; Alzheimer's disease; amyloid ; cognitive decline; sleep

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; COGNITIVE DEFECT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; HIPPOCAMPUS; HUMAN; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; NONREM SLEEP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; ANIMAL; DRUG EFFECTS; PHYSIOLOGY; SLEEP;

AGING; ALZHEIMER DISEASE; ANIMALS; HUMANS; SLEEP;

EID: 84991280080     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2016.05.002     Document Type: Review

References (120)

1. 1 Sperling, R.A., et al. Testing the right target and right drug at the right stage. Sci. Transl. Med., 3, 2011, 111cm133.
2. 2 Ohayon, M.M., et al. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 27 (2004), 1255–1273.
3. 3 Carrier, J., et al. Sleep slow wave changes during the middle years of life. Eur. J. Neurosci. 33 (2011), 758–766.
4. 4 Mander, B.A., et al. Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging. Nat. Neurosci. 16 (2013), 357–364.
5. 5 Vitiello, M.V., Recent advances in understanding sleep and sleep disturbances in older adults: growing older does not mean sleeping poorly. Curr. Dir. Psychol. Sci. 18 (2009), 316–320.
6. 6 Ancoli-Israel, S., et al. Dementia in institutionalized elderly: relation to sleep apnea. J. Am. Geriatr. Soc. 39 (1991), 258–263.
7. 7 Guarnieri, B., et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement. Geriatr. Cogn. Disord. 33 (2012), 50–58.
8. 8 Mander, B.A., et al. Impaired prefrontal sleep spindle regulation of hippocampal-dependent learning in older adults. Cereb. Cortex 24 (2014), 3301–3309.
9. 9 Hita-Yanez, E., et al. Disturbed sleep patterns in elders with mild cognitive impairment: the role of memory decline and ApoE epsilon4 genotype. Curr. Alzheimer Res, 9 (2012), 290–297.
10. 10 Prinz, P.N., et al. Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type. Neurobiol. Aging 3 (1982), 361–370.
11. 11 Westerberg, C.E., et al. Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. J. Int. Neuropsychol. Soc. 18 (2012), 490–500.
12. 12 Liguori, C., et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol. 71 (2014), 1498–1505.
13. 13 Lim, A.S., et al. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep 36 (2013), 1027–1032.
14. 14 Lim, A.S., et al. Modification of the relationship of the apolipoprotein E epsilon4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 70 (2013), 1544–1551.
15. 15 Osorio, R.S., et al. Greater risk of Alzheimer's disease in older adults with insomnia. J. Am. Geriatr. Soc. 59 (2011), 559–562.
16. 16 Yaffe, K., et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 306 (2011), 613–619.
17. 17 Kadotani, H., et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 285 (2001), 2888–2890.
18. 18 Osorio, R.S., et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 84 (2015), 1964–1971.
19. 19 Ancoli-Israel, S., et al. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J. Am. Geriatr. Soc. 56 (2008), 2076–2081.
20. 20 Moraes, W.d.S, et al. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. Sleep 29 (2006), 199–205.
21. 21 Mander, B.A., et al. Beta-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat. Neurosci. 18 (2015), 1051–1057.
22. 22 Spira, A.P., et al. Self-reported sleep and beta-amyloid deposition in community-dwelling older adults. JAMA Neurol. 70 (2013), 1537–1543.
23. 23 Sprecher, K.E., et al. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Neurobiol. Aging 36 (2015), 2568–2576.
24. 24 Sepulcre, J., et al. In vivo characterization of the early states of the amyloid-beta network. Brain 136 (2013), 2239–2252.
25. 25 Kang, J.E., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326 (2009), 1005–1007.
26. 26 Roh, J.H., et al. Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer's disease pathology. Sci. Transl. Med., 4, 2012, 150ra122.
27. 27 Xie, L., et al. Sleep drives metabolite clearance from the adult brain. Science 342 (2013), 373–377.
28. 28 Ju, Y.E., et al. Sleep and Alzheimer disease pathology–a bidirectional relationship. Nat. Rev. Neurol. 10 (2014), 115–119.
29. 29 Weller, R.O., et al. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res. Ther., 1, 2009, 6.
30. 30 Daulatzai, M.A., Evidence of neurodegeneration in obstructive sleep apnea: relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J. Neurosci. Res. 93 (2015), 1778–1794.
31. 31 Knutson, K.L., et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch. Intern. Med. 169 (2009), 1055–1061.
32. 32 Kyrtsos, C.R., Baras, J.S., Modeling the role of the glymphatic pathway and cerebral blood vessel properties in Alzheimer's disease pathogenesis. PLoS ONE, 10, 2015, e0139574.
33. 33 Buchsbaum, M.S., et al. Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci. 45 (1989), 1349–1356.
34. 15O PET study. Brain 120 (1997), 1173–1197.
35. 35 Dworak, M., et al. Sleep and brain energy levels: ATP changes during sleep. J. Neurosci. 30 (2010), 9007–9016.
36. 36 Everson, C.A., et al. Cell injury and repair resulting from sleep loss and sleep recovery in laboratory rats. Sleep 37 (2014), 1929–1940.
37. 37 Massaad, C.A., Klann, E., Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid. Redox Signal. 14 (2011), 2013–2054.
38. 38 Villafuerte, G., et al. Sleep deprivation and oxidative stress in animal models: a systematic review. Oxid. Med. Cell. Longev., 2015, 2015, 234952.
39. 39 Li, X., et al. Neuronal activity and secreted amyloid beta lead to altered amyloid beta precursor protein and presenilin 1 interactions. Neurobiol. Dis. 50 (2013), 127–134.
40. 40 Misonou, H., et al. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39 (2000), 6951–6959.
41. 41 Yatin, S.M., et al. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42). Neurobiol. Aging. 20 (1999), 325–330 discussion 339-342.
42. 42 Tabuchi, M., et al. Sleep interacts with abeta to modulate intrinsic neuronal excitability. Curr. Biol. 25 (2015), 702–712.
43. 43 Kurup, P., et al. Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61. J. Neurosci. 30 (2010), 5948–5957.
44. 44 Steriade, M., et al. A novel slow (<1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components. J. Neurosci. 13 (1993), 3252–3265.
45. 45 Ulrich, D., Amyloid-beta impairs synaptic inhibition via GABAA receptor endocytosis. J. Neurosci. 35 (2015), 9205–9210.
46. 46 Busche, M.A., et al. Rescue of long-range circuit dysfunction in Alzheimer's disease models. Nat. Neurosci. 18 (2015), 1623–1630.
47. 47 Murphy, M., et al. Source modeling sleep slow waves. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 1608–1613.
48. 48 Buckner, R.L., et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25 (2005), 7709–7717.
49. 49 Elman, J.A., et al. Neural compensation in older people with brain amyloid-beta deposition. Nat. Neurosci. 17 (2014), 1316–1318.
50. 50 Jack, C.R. Jr, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9 (2010), 119–128.
51. 51 Mattsson, N., et al. Brain structure and function as mediators of the effects of amyloid on memory. Neurology 84 (2015), 1136–1144.
52. 52 Mormino, E.C., et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132 (2009), 1310–1323.
53. 53 Staresina, B.P., et al. Hierarchical nesting of slow oscillations, spindles and ripples in the human hippocampus during sleep. Nat. Neurosci. 18 (2015), 1679–1686.
54. 54 Ngo, H.V., et al. Auditory closed-loop stimulation of the sleep slow oscillation enhances memory. Neuron 78 (2013), 545–553.
55. 55 Diekelmann, S., Born, J., The memory function of sleep. Nat. Rev. Neurosci. 11 (2010), 114–126.
56. 56 Marshall, L., et al. Boosting slow oscillations during sleep potentiates memory. Nature 444 (2006), 610–613.
57. 57 Gais, S., et al. Sleep transforms the cerebral trace of declarative memories. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 18778–18783.
58. 58 Van Der Werf, Y.D., et al. Sleep benefits subsequent hippocampal functioning. Nat. Neurosci. 12 (2009), 122–123.
59. 59 Walker, M.P., Stickgold, R., Overnight alchemy: sleep-dependent memory evolution. Nat. Rev. Neurosci., 11, 2010, 218.
60. 60 Walker, M.P., et al. Dissociable stages of human memory consolidation and reconsolidation. Nature 425 (2003), 616–620.
61. 61 Dumay, N., Sleep not just protects memories against forgetting, it also makes them more accessible. Cortex 74 (2016), 289–296.
62. 62 Gagnon, J-F., et al. Neurobiology of sleep disturbances in neurodegenerative disorders. Curr. Pharm. Des. 14 (2008), 3430–3445.
63. 63 Ju, Y.E., et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 70 (2013), 587–593.
64. 64 Lim, A.S., et al. Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease. Brain 137 (2014), 2847–2861.
65. 65 Lee, J., Finkelstein, J., Consumer sleep tracking devices: a critical review. Stud. Health Technol. Inform. 210 (2015), 458–460.
66. 66 Westerberg, C.E., et al. Memory improvement via slow-oscillatory stimulation during sleep in older adults. Neurobiol. Aging 36 (2015), 2577–2586.
67. 67 Del Felice, A., et al. Slow-oscillatory transcranial direct current stimulation modulates memory in temporal lobe epilepsy by altering sleep spindle generators: a possible rehabilitation tool. Brain Stimul. 8 (2015), 567–573.
68. 68 Prehn-Kristensen, A., et al. Transcranial oscillatory direct current stimulation during sleep improves declarative memory consolidation in children with attention-deficit/hyperactivity disorder to a level comparable to healthy controls. Brain Stimul. 7 (2014), 793–799.
69. 69 Goder, R., et al. Effects of transcranial direct current stimulation during sleep on memory performance in patients with schizophrenia. Schizophr. Res. 144 (2013), 153–154.
70. 70 Binder, S., et al. Transcranial slow oscillation stimulation during sleep enhances memory consolidation in rats. Brain Stimul. 7 (2014), 508–515.
71. 71 Eggert, T., et al. No effects of slow oscillatory transcranial direct current stimulation (tDCS) on sleep-dependent memory consolidation in healthy elderly subjects. Brain Stimul. 6 (2013), 938–945.
72. 72 Sahlem, G.L., et al. Oscillating square wave transcranial direct current stimulation (tDCS) delivered during slow wave sleep does not improve declarative memory more than sham: a randomized sham controlled crossover study. Brain Stimul. 8 (2015), 528–534.
73. 73 Papalambros, P.A., et al. Acoustic stimulation increases slow wave activity in older adults. Sleep, 38, 2015, A402.
74. 74 Bayer, L., et al. Rocking synchronizes brain waves during a short nap. Curr. Biol. 21 (2011), R461–R462.
75. 75 Trauer, J.M., et al. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann. Intern. Med. 163 (2015), 191–204.
76. 76 Bettica, P., et al. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 37 (2012), 1224–1233.
77. 77 Feld, G.B., et al. Slow wave sleep induced by GABA agonist tiagabine fails to benefit memory consolidation. Sleep 36 (2013), 1317–1326.
78. 78 Vienne, J., et al. Differential effects of sodium oxybate and baclofen on EEG, sleep, neurobehavioral performance, and memory. Sleep 35 (2012), 1071–1083.
79. 79 Walsh, J.K., et al. Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss. Sleep 33 (2010), 1217–1225.
80. 80 Hall-Porter, J.M., et al. The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation. J. Clin. Sleep Med. 10 (2014), 27–34.
81. 81 Mednick, S.C., et al. The critical role of sleep spindles in hippocampal-dependent memory: a pharmacology study. J. Neurosci. 33 (2013), 4494–4504.
82. 82 Shih, H.I., et al. An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine, 94, 2015, e809.
83. 83 Roh, J.H., et al. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease. J. Exp. Med. 211 (2014), 2487–2496.
84. 84 Moe, K.E., et al. Symposium: Cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J. Sleep Res. 4 (1995), 15–20.
85. 85 Reynolds, C.F. 3rd, et al. Rapid eye movement sleep deprivation as a probe in elderly subjects. Arch. Gen. Psychiatry 47 (1990), 1128–1136.
86. 86 Brayet, P., et al. Quantitative EEG of rapid-eye-movement sleep: a marker of amnestic mild cognitive impairment. Clin. EEG Neurosci. 47 (2016), 134–141.
87. 87 Hassainia, F., et al. Quantitative EEG and statistical mapping of wakefulness and REM sleep in the evaluation of mild to moderate Alzheimer's disease. Eur. Neurol. 37 (1997), 219–224.
88. 88 Mesulam, M., et al. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann. Neurol. 55 (2004), 815–828.
89. 89 Mufson, E.J., et al. Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease. Ann. Neurol. 24 (1988), 623–629.
90. 90 Lee, M.G., et al. Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. J. Neurosci. 25 (2005), 4365–4369.
91. 91 Saper, C.B., et al. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 24 (2001), 726–731.
92. 92 Kerbler, G.M., et al. Basal forebrain atrophy correlates with amyloid beta burden in Alzheimer's disease. Neuroimage Clin. 7 (2015), 105–113.
93. 93 Geula, C., et al. Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 67 (2008), 309–318.
94. 94 Song, Y., et al. Relationships between sleep stages and changes in cognitive function in older men: the MrOS sleep study. Sleep 38 (2015), 411–421.
95. 95 Goldstein, A.N., Walker, M.P., The role of sleep in emotional brain function. Annu. Rev. Clin. Psychol. 10 (2014), 679–708.
96. 96 Kensinger, E.A., et al. Effects of Alzheimer disease on memory for verbal emotional information. Neuropsychologia 42 (2004), 791–800.
97. 97 Torres, B., et al. Facial expression recognition in Alzheimer's disease: a longitudinal study. Arq. Neuropsiquiatr. 73 (2015), 383–389.
98. 98 Zhao, Q.F., et al. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: systematic review and meta-analysis. J. Affect. Disord. 190 (2016), 264–271.
99. 99 Cherbuin, N., et al. Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis. BMJ Open, 5, 2015, e008853.
100. 100 Yaffe, K., et al. Posttraumatic stress disorder and risk of dementia among US veterans. Arch. Gen. Psychiatry 67 (2010), 608–613.
101. 101 Snowdon, M.B., et al. Longitudinal association of dementia and depression. Am. J. Geriatr. Psychiatry 23 (2015), 897–905.
102. 102 Craig, D., et al. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Am. J. Geriatr. Psychiatry 13 (2005), 460–468.
103. 103 Schöll, M., et al. PET imaging of Tau deposition in the aging human brain. Neuron 89 (2016), 971–982.
104. 104 Witton, J., et al. Disrupted hippocampal sharp-wave ripple-associated spike dynamics in a transgenic mouse model of dementia. J. Physiol., 2014, 10.1113/jphysiol.2014.282889 Published online December 2014.
105. 105 Menkes-Caspi, N., et al. Pathological tau disrupts ongoing network activity. Neuron 85 (2015), 959–966.
106. 106 Rauchs, G.r., et al. Is there a link between sleep changes and memory in Alzheimer's disease?. Neuroreport, 19, 2008, 1159.
107. 107 Di Meco, A., et al. Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol. Aging 35 (2014), 1813–1820.
108. 108 Rothman, S.M., et al. Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Aβ and pTau in a mouse model of Alzheimer's disease. Brain Res. 1529 (2013), 200–208.
109. 109 Iliff, J.J., et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J. Neurosci. 34 (2014), 16180–16193.
110. 110 Fronczek, R., et al. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol. Aging 33 (2012), 1642–1650.
111. 111 Ishii, T., Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol. 6 (1966), 181–187.
112. 112 Kasanuki, K., et al. Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies. Neurosci. Lett. 569 (2014), 68–73.
113. 113 Gallone, S., et al. Is HCRTR2 a benetic risk factor for Alzheimer's disease?. Dement. Geriatr. Cogn. Disord. 38 (2014), 245–253.
114. 114 Dauvilliers, Y.A., et al. Hypocretin and brain beta-amyloid peptide interactions in cognitive disorders and narcolepsy. Front. Aging Neurosci., 6, 2014, e00119.
115. 115 Deuschle, M., et al. Hypocretin in cerebrospinal fluid is positively correlated with Tau and pTau. Neurosci. Lett. 561 (2014), 41–45.
116. 116 Friedman, L.F., et al. In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1. Neurology 68 (2007), 793–794.
117. 117 Wennstrom, M., et al. Altered CSF orexin and alpha-synuclein levels in dementia patients. J. Alzheimers Dis. 29 (2012), 125–132.
118. 118 Coban, A., et al. Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance. Am. J. Alzheimers Dis. Other Demen. 28 (2013), 606–611.
119. 119 Scammell, T.E., et al. Coexistence of narcolepsy and Alzheimer's disease. Neurobiol. Aging 33 (2012), 1318–1319.
120. 120 Heier, M.S., et al. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy. Sleep Med. 15 (2014), 614–618.